Relation of interleukin-1β gene to treatment response in chronic patients infected with HCV genotype 4
Author(s) -
Moataza H Omran,
Noha E. Ibrahim,
Samar Samir Youssef,
Basma E Fatouh,
Wael Nabil,
Magdy M El-Shami,
Mostafa K. El Awady
Publication year - 2013
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.3823
Subject(s) - genotype , virology , immunology , medicine , gene , interleukin , biology , genetics , cytokine
Hepatitis C virus (HCV) infection results in chronic hepatitis in more than 70% of infected patients, while 20-30% of patients recover spontaneously. This strengthens the role of the host genetic factors in either spontaneous or drug-induced viral clearance. The aim of this study was to investigate the relationship between interleukin-1β +3953 gene polymorphism and the response to interferon therapy in chronic HCV patients infected with genotype 4.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom